Ringpu Bio-Technology announces share repurchase progress

Tianjin Ringpu Bio-Technology (SZSE:300119) announced an update on its share repurchase program, initially approved on November 1, 2024. As of February 28, 2025, the company has repurchased 5,404,251 shares, representing 1.3748% of the company's total share capital. The shares were acquired through centralized competitive bidding, with prices ranging from ¥17.13 to ¥19.49 per share. The total expenditure for the repurchase amounted to ¥119,984,514.99 (excluding transaction costs). The company stated that the repurchases comply with the company's repurchase plan and relevant laws and regulations. Ringpu Bio-Technology indicated that it will continue to implement the repurchase plan based on market conditions and in accordance with regulations, urging investors to pay attention to investment risks.